Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 13, 2013

View Archived Issues

Nanoparticle-mediated vaccine delivery system for pulmonary immunization

DCBCI-0901 shows promising activity in in vitro and in vivo cancer models

KKHP-60159 reported to have ideal antipsychotic profile

Dual D2 and H3 blockade as a putative strategy for schizophrenia: Angita's AG-0098

ChemoCentryx describes novel small-molecule inhibitors of CCR1 and CCR6

Patisiran receives FDA fast track designation for TTR-mediated amyloidosis

Affinium obtains QIDP designation for AFN-1252, completes dosing in study of new prodrug

Nationwide Children's Hospital discloses new antimicrobial peptides for bacterial infections

Novel HBV expression inhibitors patented by Isis Pharmaceuticals

GlaxoSmithKline prepares new RORgamma modulators

Janssen Pharmaceutica synthesizes new antibacterial agents

ME-3398, a novel PDE10A inhibitor for the treatment of schizophrenia

Herceptin conjugate could penetrate blood-tumor barrier better than Herceptin

Ligand begins phase I trial of LGD-6972 for type 2 diabetes

Servier's voluntary public offer for outstanding shares in Egis Pharmaceuticals closes

Innate Pharma presents a novel cytotoxic antibody against KIR3DL2-expressing cancers

FDA considers NDA filing for eteplirsen premature

BioFocus signs agreement with Biogen Idec in target discovery for scleroderma

FDA grants QIDP designation to oritavancin

Preclinical antiviral efficacy seen in Tekmira's TKM-Ebola and TKM-Marburg programs

Japanese NHI price listing of Kadcyla postponed

Anacor reports findings for AN-2728 in pediatric and adolescent patients with atopic dermatitis

Boehringer Ingelheim seeks European approval of tiotropium Respimat for asthma

Isis earns milestone payment for phase II study of ISIS-SMNRx

Pieris achieves new milestone in Daiichi Sankyo Anticalin collaboration

Immunocore achieves first milestone under collaboration with GSK

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...